Frank Witney - 28 Jun 2024 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role: Director
Signature: /s/ Frank Witney by Agnieszka Gallagher, Attorney-in-Fact
Issuer symbol: LAB
Transactions as of: 28 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 02 Jul 2024, 17:30:17 UTC
Previous filing: 06 Jun 2024
Next filing: 01 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LAB	Common Stock	Award	$0	+43,128	+59%	$0.000000	116,270	28 Jun 2024	Direct	F1
holding	LAB	Common Stock						4,225	28 Jun 2024	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LAB	Stock Option (Right to buy)	Award	$0	+72,213		$0.000000	72,213	28 Jun 2024	Common Stock	72,213	$1.77	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 28, 2025 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.
F2	Shares held indirectly by First Amended and Restated Revocable Trust Agreement for The Franklin R. Witney and Catherine J. Caulfield-Witney Trust Agreement Dated September 25, 2009 (dated July 31, 2018).
F3	The Option becomes exercisable in twelve equal monthly installments beginning on July 28, 2024, subject to the Reporting Person's continued service through the applicable vesting date.